NDC 13845-1201

CYCLOSERINE

Cycloserine

CYCLOSERINE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Parsolex Gmp Center, Inc.. The primary component is Cycloserine.

Product ID13845-1201_1d21c18e-a54d-4c62-9c3b-ee0912a50950
NDC13845-1201
Product TypeHuman Prescription Drug
Proprietary NameCYCLOSERINE
Generic NameCycloserine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2009-03-01
Marketing CategoryANDA / ANDA
Application NumberANDA060593
Labeler NameParsolex Gmp Center, Inc.
Substance NameCYCLOSERINE
Active Ingredient Strength250 mg/250mg
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 13845-1201-3

40 CAPSULE in 1 BOTTLE (13845-1201-3) > 250 mg in 1 CAPSULE (13845-1201-1)
Marketing Start Date2009-03-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13845-1201-3 [13845120103]

CYCLOSERINE CAPSULE
Marketing CategoryANDA
Application NumberANDA060593
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-03-01

NDC 13845-1201-1 [13845120101]

CYCLOSERINE CAPSULE
Marketing CategoryANDA
Application NumberANDA060593
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-03-01

Drug Details

Active Ingredients

IngredientStrength
CYCLOSERINE250 mg/250mg

OpenFDA Data

SPL SET ID:10727aa8-a03e-4b61-9a80-a024cb4a2d28
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197551
  • UPC Code
  • 0313845120131
  • NDC Crossover Matching brand name "CYCLOSERINE" or generic name "Cycloserine"

    NDCBrand NameGeneric Name
    13845-1201CYCLOSERINECYCLOSERINE
    13845-1202CycloserineCycloserine
    33342-462CycloserineCycloserine
    13845-1200SEROMYCINCYCLOSERINE
    13845-1203SeromycinCycloSERINE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.